There is a need for new IVD products for rare diseases: GlobalData Only Cystic Fibrosis has two active clinical trials for IVD products out of over 1,400 active IVD trials
Takeda launches Enzyme Replacement Therapy portfolio for lysosomal storage disorders in India Takeda brings to market Idursulfase for hunter syndrome, Velaglucerase Alpha for gaucher disease and Agalsidase Alfa for fabry…
